Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical catheter-directed thrombolysis). There are no ...

Inquis Medical has reported that the single-arm trial of its Aventus thrombectomy system in treating individuals with acute intermediate-risk pulmonary embolism (PE) met its primary endpoints.

Current advances in endovascular therapy have resulted in various endovascular thrombectomy systems that can effectively remove a large venous thrombus burden, which may represent a potential ...

The stock carries a Zacks Rank #3 (Hold). Penumbra is demonstrating strong growth within the company’s Thrombectomy business, banking on the rapid increase in sales of the company’s vascular ...

The fully mechanical Pounce Thrombectomy Platform utilizes proprietary ... it reduces the use of general anesthesia and post-procedural complications, making it a strong first-line treatment ...

The company is developing next-generation thrombectomy technology that provides physicians with improved control and precision, enhances procedural efficiency, and minimizes blood loss.

today announced results from its AVENTUS Trial evaluating the safety and efficacy of the company’s AVENTUS Thrombectomy System. The results were presented by Dr. Jun Li, Co-Director of the ...